Saurabh Gupta
Overview
Explore the profile of Saurabh Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
474
Citations
3198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kaur N, Gupta S, Pal J, Bansal Y, Bansal G
Comput Biol Chem
. 2025 Feb;
116:108371.
PMID: 39954613
BACE-1 is a prime therapeutic target for treatment of Alzheimer disease as it cleaves the β-site of APP leading to formation of amyloid plaques. A dataset of 229 benzo-fused heterocyclic...
12.
Gupta S, Luxami V, Paul K
ACS Appl Bio Mater
. 2025 Jan;
8(2):1077-1096.
PMID: 39874063
It has been well accumulated that G-quadruplex (G4-DNA) has great anticancer relevance, and various heterocyclic moieties have been synthesized and examined as potent G4-DNA binders with promising anticancer activity. Here,...
13.
Galsky M, Kockx M, Roels J, Van Elzen R, Guan X, Yuen K, et al.
Cancer Immunol Res
. 2025 Jan;
PMID: 39853278
Testing for PD-L1 expression by immunohistochemistry (IHC) is used to predict immune checkpoint blockade (ICB) benefit but has performed inconsistently in urothelial cancer (UC) clinical trials. Different approaches are used...
14.
Kaur R, Gupta S, Kulshrestha S, Khandelwal V, Pandey S, Kumar A, et al.
Cells
. 2025 Jan;
14(1.
PMID: 39791706
Breast cancer is a cancer with global prevalence and a surge in the number of cases with each passing year. With the advancement in science and technology, significant progress has...
15.
Gupta S, Luxami V, Paul K
ACS Appl Mater Interfaces
. 2025 Jan;
17(3):4380-4399.
PMID: 39772461
Resistance by bacteria to available antibiotics is a threat to human health, which demands the development of new antibacterial agents. Considering the prevailing conditions, we have developed a library of...
16.
Kaur R, Pandey S, Gupta S, Singh J
Exp Neurol
. 2024 Dec;
385:115134.
PMID: 39740737
Alzheimer's disease (AD), a diverse neurodegenerative disease, is the leading cause of dementia, accounting for 60-80 % of all cases. The pathophysiology of Alzheimer's disease is unknown, and there is...
17.
Unusual Canal Morphology in Mandibular Premolars With Two Distal and One Mesial Canal: A Case Series
A J, Jayakumar Nair S, Gupta S, Chansoria H, Rawat G
Cureus
. 2024 Dec;
16(11):e73832.
PMID: 39691135
Mandibular premolars exhibit intricate and diverse root canal anatomy, presenting substantial challenges in endodontic treatment. Uncommon variations, such as the presence of three canals, demand meticulous diagnostic and therapeutic approaches...
18.
Yadav S, Rajnish R, Aggarwal A, Gupta S, Elhence A, Chithira A
J Orthop Case Rep
. 2024 Dec;
14(12):66-72.
PMID: 39669057
Introduction: Osteochondroma, a common benign bone tumor, predominantly affects young individuals, with a higher prevalence in males. It typically manifests as a bony growth capped with cartilage near bone growth...
19.
Chauhan P, Begum M, Narapureddy B, Gupta S, Wadhwa K, Singh G, et al.
Mol Neurobiol
. 2024 Dec;
PMID: 39648189
Viruses pose a significant challenge and threat to human health, as demonstrated by the current COVID-19 pandemic. Neurodegeneration, particularly in the case of Alzheimer's disease (AD), is significantly influenced by...
20.
Kollipara S, Prabhat P, Saha P, Gupta S, Naidu V, Ahmed T
AAPS PharmSciTech
. 2024 Dec;
26(1):1.
PMID: 39627629
Mesalamine is a locally acting anti-inflammatory drug used to treat mild to moderate ulcerative colitis. Because of complex formulation principle and high in vivo variability, development of bioequivalent formulation for...